Sidharth Tyagi Selected Research

Arginine (L-Arginine)

1/2019

A mutation in CaV2.1 linked to a severe neurodevelopmental disorder impairs channel gating.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sidharth Tyagi Research Topics

Disease

4	Pain (Aches) 12/2024 - 01/2023
2	Neurodevelopmental Disorders 01/2022 - 01/2019
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 01/2019
2	Channelopathies 01/2022 - 01/2019
1	Neuralgia (Stump Neuralgia) 01/2024
1	Hypesthesia (Numbness) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Cerebellar Ataxia (Dysmetria) 01/2019
1	Muscle Hypotonia (Hypotonia) 01/2019
1	Atrophy 01/2019

Drug/Important Bio-Agent (IBA)

3	voltage-dependent calcium channel (P-Q type)IBA 01/2022 - 01/2019
2	Ion Channels (Ion Channel)IBA 01/2023 - 01/2023
1	Proteins (Proteins, Gene)FDA Link 12/2024
1	CannabinoidsIBA 01/2024
1	Voltage-Gated Sodium ChannelsIBA 01/2023
1	SodiumIBA 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	Monomeric GTP-Binding ProteinsIBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Arginine (L-Arginine)FDA Link 01/2019
1	Proline (L-Proline)FDA Link 01/2019

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2023 - 01/2019
1	Therapeutics 01/2023